KKKamran Ahmed Khan

Kamran Ahmed Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kamran Ahmed Khan has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Jawaid Akbar Sial

    National Institute of Cardiovascular Diseases (NICVD), Department of Adult Cardiology, Karachi, Pakistan

    3 shared publications
  • Jehangir Ali Shah

    Department of Adult Cardiology & Neurology, National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan

    3 shared publications
  • Musa Karim

    National Institute of Cardiovascular Diseases (NICVD), Department of Adult Cardiology, Karachi, Pakistan

    3 shared publications
  • Tahir Saghir

    National Institute of Cardiovascular Diseases (NICVD), Department of Adult Cardiology, Karachi, Pakistan

    3 shared publications
  • Abdul Samad Achakzai

    National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan

    2 shared publications
  • Ali Ammar

    Department of Adult Cardiology & Neurology, National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan

    2 shared publications

Latest Publications

  • Open Access

    Significance of On-admission Impaired Estimated Glomerular Filtration Rate for the Assessment of Immediate Outcomes after Percutaneous Coronary Intervention

    by Khalid Iqbal Bhatti, Kamran Ahmed Khan, Jehangir Ali Shah, Bashir Ahmed Solangi, Salik Ahmed, Ahsan Ali, Sanjana Karera, Kalsoom Chachar, Fawad Farooq, Jawaid Akbar Sial

    Objectives: Impaired baseline estimated glomerular filtration rate (eGFR) has been associated with a heightened risk of major adverse clinical events (MACE) following percutaneous coronary intervention (PCI). Early recognition of renal dysfunction on admission can help optimize clinical decision-making and improve post-PCI outcomes. This study aimed to evaluate the prognostic significance of baseline eGFR among patients with acute myocardial infarction (AMI) and its impact on immediate in-hospital outcomes after PCI. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes.

  • Open Access

    Successful Retrieval of Dislodged Stent and Fractured Balloon After Entrapment in One Setting

    by Ali Hyder Nazeer, Abdul Hameed, Iram Jehan Balouch, Khalid Iqbal Bhatti, Kamran Khan


  • Open Access

    Case report: Navigating the challenges: successful mechanical thrombectomy in a case of persistent primitive hypoglossal artery

    by Kamran Ahmed Khan, Irfan Amjad Lutfi, Jehangir Ali Shah, Salman Farooq, Shahnoor Ahmed, Bashir Ahmed Solangi, Ayan Ahmed Khan, Fazal Zaidi, Ali Ammar, Nadeem Qamar

    Persistent primitive hypoglossal artery (PPHA) is a highly uncommon abnormal connection between the internal carotid artery (ICA) and vertebral artery (VA), with reported incidences ranging from 0.027 to 0.26%. Attempting endovascular intervention in such cases presents a considerable challenge as it carries a higher risk of embolization and other procedure-related complications that may affect a wide area of the brain. We present a case study involving the utilization of mechanical thrombectomy (MT) to treat an ischemic stroke in the M1 segment of the middle cerebral artery (MCA) despite the presence of PPHA. Performing mechanical thrombectomy in an anomalous vascular connection is feasible; however, it necessitates heightened vigilance, thorough knowledge of the anatomy, and utmost caution.


  • Open Access

    Development and Validation of a Novel Risk Stratification Model for Slow-Flow/No-Reflow During Primary Percutaneous Coronary Intervention (the RK-SF/NR Score)

    by Rajesh Kumar, Ali Ammar, Tahir Saghir, Jawaid Akbar Sial, Kamran Ahmed Khan, Jehangir Ali Shah, Abdul Hakeem Shaikh, Syed Nadeem Hassan Rizvi, Nadeem Qamar, Musa Karim


  • Open Access

    Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)

    by Kamran Ahmed Khan, Nadeem Qamar, Tahir Saghir, Jawaid Akbar Sial, Dileep Kumar, Rajesh Kumar, Danish Qayyum, Umamah Yasin, Javed Jalbani, Musa Karim

    Background: Intracoronary epinephrine has been effectively used in treating refractory no-reflow, but there is a dearth of data on its use as a first-line drug in normotensive patients in comparison to the widely used adenosine. Methods: In this open-labeled randomized clinical trial, 201 patients with no-reflow were randomized 1:1 into intracoronary epinephrine as the treatment group and intracoronary adenosine as the control group and followed for 1 month. The primary end points were improvement in coronary flow, as assessed by TIMI (Thrombolysis in Myocardial Infarction) flow, frame counts, and myocardial blush. Secondary end points were in-hospital and short-term mortality and major adverse cardiac events. Results: In all, 101 patients received intracoronary epinephrine and 100 patients received adenosine. Epinephrine was generally well tolerated with no immediate table death or ventricular fibrillation. No-reflow was more effectively improved with epinephrine with final TIMI III flow (90.1% versus 78%, P =0.019) and final corrected TIMI frame count (24±8.43 versus 26.63±9.22, P =0.036). However, no significant difference was observed in final grade III myocardial blush (55.4% versus 45%, P =0.139), mean reduction of corrected TIMI frame count (−25.71±11.79 versus −26.08±11.71, P =0.825), in-hospital and short-term mortality, and major adverse cardiac events. Conclusions: Epinephrine is relatively safe to use in no-reflow in normotensive patients. A significantly higher frequency of post-treatment TIMI III flow grade and lower final corrected TIMI frame count with relatively better achievement of myocardial blush grade III translate into it displaying relatively better efficacy than adenosine. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04699110.


  • Open Access

    Comparison of angiographic results and clinical outcomes of no-reflow after stenting in left anterior descending (LAD) versus non-LAD culprit STEMI

    by Kamran Ahmed Khan, Rajesh Kumar, Jehangir Ali Shah, Fawad Farooq, Quratulain Shaikh, Dileep Kumar, Jawaid Akbar Sial, Tahir Saghir, Abdul Samad Achakzai, Musa Karim

    Objectives: No-reflow is a complication that frequently occurs after stenting during primary percutaneous coronary intervention. In this study, we focused on angiographic results and clinical outcomes after no-reflow in the left anterior descending (LAD) artery versus non–left anterior descending artery ST-elevation myocardial infarction (STEMI). Methods: In this prospective study, a total of 201 patients who had developed no-reflow during primary percutaneous coronary intervention were enrolled. The patients were divided into left anterior descending artery culprit and non-left anterior descending artery culprit groups. The primary endpoints were final thrombolysis in myocardial infarction flow, corrected thrombolysis in myocardial infarction frame count and final myocardial blush grade. Secondary endpoints were major adverse cardiovascular events in-hospital and at 1 month. Results: Out of the 201 patients, 60.19% had culprit left anterior descending artery. Pulse rate, baseline systolic and diastolic blood pressure, single-vessel disease, left ventricular ejection fraction 40% were significantly greater in the non–left anterior descending artery group. However, for both in-hospital and at 30 days, overall major adverse cardiovascular event was similar in the two groups. The demographics, clinical and medication profiles and the routes used to treat no-reflow were all comparable in both groups. Conclusions: No-reflow in left anterior descending artery ST-elevation myocardial infarction is associated with lower final thrombolysis in myocardial infarction III flow, higher thrombolysis in myocardial infarction frame count and relatively lower Grade III myocardial blush than non-left anterior descending artery ST-elevation myocardial infarction with subsequent lower left ventricular ejection fraction and a higher frequency of in-hospital heart failure and hospitalisation due to heart failure.


  • TERRITORIAL IMPACT ON CLINICAL OUTCOMES IN YOUNG POPULATION WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

    by Kamran Ahmed Khan, Mahesh Kumar Batra, Dileep Kumar, Sajjad Ali, Vinesh Kumar, Rajesh Kumar, Danish Qayyum, Tahir Saghir, Abdul Samad Achakzai, Jawaid Akbar Sial, et al.

    Objective: ST-segment elevation myocardial infarction (STEMI) at younger age though infrequent but very crucial entity, but there is dearth of available data, however, a rising trend has noticed recently in Asian countries. The aim was to see the territorial and clinical profile influence on overall outcomes of young individuals (≤35 years) with STEMI. Methodology: Patients with STEMI having age of ≤35 years during August 2020 to December 2020 were recruited and divided into left anterior descending artery (LAD)-culprit and non-LAD-culprit STEMI groups in this prospective observational study. Territorial angiographic and clinical characteristics were compared. Results: 1435 STEMI patients underwent coronary angiogram, 5.3% (94) were ≤35 years of age. LAD was culprit in 74.4% of STEMI mainly as a single vessel disease (SVD) involving the proximal segment as major territorial angiographic finding while 25.5% were non-LAD-culprit STEMI. Obesity, smoking, smokeless tobacco use especially gutka, were frequent in LAD-culprit group. In-hospital and at 3 months mortality was 2.1% (2) and 7.1% (5) respectively, all related to LAD territory. Rate of safe discharges and back to routine was 97.2% vs.100% and 70% vs.79.1% (72), respectively were comparable in both groups. Conclusion: LAD predominantly its proximal segment is the commonest culprit territory in patients with STEMI in youth with significant association to obesity, smoking and smokeless tobacco use especially gutka. LAD-culprit STEMI is the major territorial determinant for mortality and heart failure, however, overall clinical outcomes were reasonably good and comparable with non-LAD-culprit STEMI considering alive discharges and back to routine life.